Thus, we demonstrate that c-Myc may upregulate the transcription of PFKP by binding to the promoter of the PFKP gene, and both PFKP and c-Myc may contribute to the prognosis of HNSCC. This evidence concerns the gene PFKP and head and neck squamous cell carcinoma.